<html>
<head>PUBMED IDs for EBF3</head>
<body bgcolor='#C5F0F2'><h1>EBF3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17018599/'>An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis.</a> October 5  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18559491/'>Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma.</a> June 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18845077/'>[Construction of eukaryotic expression vector for EBF3 and EGFP fusion protein and its expression in HepG2 cells].</a> October 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19934318/'>Disruption of transforming growth factor-beta signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis.</a> January 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19996307/'>Emerging roles of the EBF family of transcription factors in tumor suppression.</a> February 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20029986/'>HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas.</a> May 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20029985/'>Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer.</a> December 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20029976/'>Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness.</a> March 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20937862/'>Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21132329/'>Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease.</a> April 7  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21387304/'>Aberrant DNA methylation and tumor suppressive activity of the EBF3 gene in gastric carcinoma.</a> March 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23321599/'>Human metastable epiallele candidates link to common disorders.</a> September 7  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23321590/'>Association between the ghrelin Leu72Met polymorphism and type 2 diabetes risk: a meta-analysis.</a> April 2  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23456299/'>Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis.</a> May 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24153013/'>Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells.</a> July 11  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25609158/'>Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.</a> March 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28017373/'>Mutations in EBF3 Disturb Transcriptional Profiles and Cause Intellectual Disability, Ataxia, and Facial Dysmorphism.</a> December 27  2016<br></body></html>
